Noriaki Hirayama

Dr. Noriaki Hirayama

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2010 in Protein Engineering, Design and Selection
Verified
Journal Article
Open access
PDF file
SSShinji Soga
Shinji Soga
DKDaisuke Kuroda
Daisuke Kuroda
HSHiroki Shirai
Hiroki Shirai
MKMasato Kobori
Masato Kobori
NHNoriaki Hirayama
Noriaki Hirayama
We identified specific amino acid propensities at the interfaces of antigen–antibody interactions in non-redundant qualified antigen–antibody complex structures from Protein Data Bank. Propensities were expressed by the frequency of each of the 20 × 20 standard amino acid pairs that appeared at the interfaces of the complexes and were named the antibody-specific epitope propensity (ASEP) index. Using this index, we developed a novel method of predicting epitope residues for individual antibodies by narrowing down candidate epitope residues which was predicted by the conventional method. The 74 benchmarked antigens were used in ASEP prediction. The efficiency of this method was assessed using the leave-one-out approach. On elimination of residues with ASEP indices in the lowest 10% of all measured, true positives were enriched for 49 antigens. On subsequent elimination of residues with ASEP indices in the lowest 50%, true positives were enriched for 40 of the 74 antigens assessed. The ASEP index is the first benchmark proposed to predict epitope residues for an individual antibody. Used in combination with mutation experiments, this index has the potential to markedly increase the success ratio of epitope analysis.

1 August 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
RNRyosuke Nakamura
Ryosuke Nakamura
TOTakeshi Ozeki
Takeshi Ozeki
NHNoriaki Hirayama
Noriaki Hirayama
ASAkihiro Sekine
Akihiro Sekine
TYTaiki Yamashita
Taiki Yamashita
EMEishin Morita
Eishin Morita

2 September 2006
Verified
Book Chapter
Closed access
PDF file
KSKenichi Sakai
Kenichi Sakai
RSRumiko Sakurai
Rumiko Sakurai
NHNoriaki Hirayama
Noriaki Hirayama

13 December 2004 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
KSKenichi Sakai
Kenichi Sakai
RSRumiko Sakurai
Rumiko Sakurai
TAToshio Akimoto
Toshio Akimoto
NHNoriaki Hirayama
Noriaki Hirayama
We have recently found the first example of dielectrically controlled optical resolution (DCR). By adjusting the dielectric constant of the solvent used in the resolution process, each optical isomer of (R,S)-α-amino-ε-caprolactam can be selectively obtained using N-tosyl-(S)-phenylalanine as a chiral selector. The molecular mechanism of DCR has been investigated by comparing the molecular and crystal structures of the optical selector, its target substrate and their diastereomeric salts. Strong hydrophobic interactions between the phenyl rings of the optical selector govern the molecular aggregation of the selectors and form a hydrophilic layer in which molecular recognition takes place. The recognition site in the hydrophilic layer can inherently identify both of the isomers. The dielectric constant of the solvent used in the discrimination process controls the intermolecular interaction which determines the isomer to be selected. The molecular mechanism of DCR disclosed in this study strongly suggests that DCR is not a specific but a general phenomenon. This method can be applicable to a large variety of optical resolution processes.

19 June 2006 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
KSKenichi Sakai
Kenichi Sakai
MYMasami Yokoyama
Masami Yokoyama
RSRumiko Sakurai
Rumiko Sakurai
NHNoriaki Hirayama
Noriaki Hirayama

12 October 2013 in Journal of Toxicology
Verified
Journal Article
Open access
PDF file
HIHideto Isogai
Hideto Isogai
HMHiroko Miyadera
Hiroko Miyadera
MUMayumi Ueta
Mayumi Ueta
CSChie Sotozono
Chie Sotozono
SKShigeru Kinoshita
Shigeru Kinoshita
NHNoriaki Hirayama
Noriaki Hirayama
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe drug hypersensitivities with high mortality. Typical over-the-counter drugs of cold medicines are suggested to be causative. As multiple ingredients are generally contained in cold medicines, it is of particular interest to investigate which ingredients are responsible for SJS/TEN. However, experimental examination of causal relationships between SJS/TEN and a particular drug molecule is not straightforward. Significant association between HLA-A*02:06 and SJS/TEN with severe ocular surface complications has been observed in the Japanese. In the present study, we have undertakenin silicodocking simulations between various ingredients contained in cold medicines available in Japan and the HLA-A*02:06 molecule. We use the composite risk index (CRI) that is the absolute value of the binding affinity multiplied by the daily dose to assess the potential risk of the adverse reactions. The drugs which have been recognized as causative drugs of SJS/TEN in Japan have revealed relatively high CRI, and the association between SJS/TEN and HLA-A*02:06 has been qualitatively verified. The results have also shown that some drugs whose links to SJS/TEN have not been clinically recognized in Japan show the high CRI and suggested that attention should be paid to their adverse drug reactions.